Call for Comment: SITC Renal Cell Carcinoma CPG v3.0 Until May 8

posted 26 days ago
Manuscript Title: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma v3.0 Draft Manuscript Summary The Society for Immunotherapy ...
0 comments

Lymphoma CPG Update V1.4 Now Available

posted 03-24-2025
An update to " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma ” is now available. In accordance with the Institute of Medicine’s Standards for Developing ...
0 comments

Melanoma CPG Addendum v3.2 Now Available

posted 03-18-2025
An addendum to the " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma " is now available. In accordance with the Institute of Medicine’s Standards for ...
0 comments

Apply to Join the Cancer Immunotherapy Guidelines Oversight Committee

posted 02-26-2025
The Society for Immunotherapy of Cancer (SITC) is seeking volunteers to join the Cancer Immunotherapy Guidelines (CIG) Oversight Committee, which plays a key role in guiding the society’s clinical practice guideline development ...
0 comments

Head and Neck Squamous Cell Carcinoma CPG Update v1.1 Now Available

posted 11-18-2024
An update to " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of head and neck squamous cell carcinoma ” is now available. In accordance with the Institute of ...
0 comments

Urothelial Cancer CPG Update v2.4 Now Available

posted 11-01-2024
An update to " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer " is now available. In accordance with the Institute of Medicine’s Standards ...
0 comments
 
User-Generated   SITCGuidelines

SITC CPG Mobile App Receives 2024 President's Award from the American Association of Medical Society Executives

posted 08-06-2024
The Society for Immunotherapy of Cancer (SITC) is pleased to announce that the SITC Clinical Practice Guidelines (CPG) Mobile App has been selected by the American Association of Medical Society Executives (AAMSE) to receive ...
0 comments

ICI-Related Adverse Events CPG Updates v1.1 and v1.2 Now Available

posted 07-18-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

Urothelial Cancer CPG Update v2.3 Now Available

posted 07-12-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

Melanoma CPG Update v3.1 Now Available

posted 06-27-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

Gynecologic Cancer CPG Update v1.1 Now Available

posted 06-20-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

Breast Cancer CPG Update v1.2 Now Available

posted 06-03-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

SITC Living Guidelines – Rapid Updates to Published Clinical Practice Guidelines

posted 05-23-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

Nonmelanoma Skin Cancer CPG Update v1.1 Now Available

posted 03-19-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

New SITC Melanoma CPG Published in JITC

posted 10-18-2023
On behalf of the Society for Immunotherapy of Cancer (SITC) and the SITC Melanoma Guideline Expert Panel, we are pleased to announce the publication of SITC’s Melanoma Clinical Practice Guideline (CPG), version 3.0. This ...
0 comments

New SITC Gynecologic Cancer CPG Published in JITC

posted 06-09-2023
On behalf of the Society for Immunotherapy of Cancer (SITC) and the SITC Gynecologic Cancer Immunotherapy Guideline Expert Panel, we are pleased to announce the publication of SITC’s Gynecologic Cancer Clinical Practice ...
0 comments

New SITC Gastrointestinal Cancer CPG Published in JITC

posted 06-07-2023
SITC is pleased to announce the publication of our newest guideline, " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer. " Clinicians ...
0 comments

Open Comment Period for SITC’s Melanoma Guideline Closes March 16

posted 02-23-2023
The Society for Immunotherapy of Cancer (SITC) Melanoma Immunotherapy Guideline Expert Panel is pleased to invite public comment on the draft clinical practice guideline (CPG) “Society for Immunotherapy of Cancer (SITC) clinical ...
0 comments

Open Comment Periods for SITC’s Gynecologic Cancer and Gastrointestinal Cancer Guidelines Close January 27

posted 01-12-2023
The Society for Immunotherapy of Cancer (SITC) is pleased to invite public comment on two new draft clinical practice guidelines (CPGs): “Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy ...
0 comments

Help SITC Performance Test Our Next Quality Measure – Apply by January 5

posted 12-20-2022
The Society for Immunotherapy of Cancer (SITC) is currently recruiting practices for clinician-level testing of the draft quality measure: Positive PD-L1 Biomarker Expression Test Result Prior to First-Line Immune Checkpoint ...
0 comments

Back to SITC Cancer Immunotherapy Guidelines